DOAC - Dosing Options in AntiCoagulation Prophylaxis
DOAC - Dosing Options in AntiCoagulation Prophylaxis
Recruiting · NCT07005024 · Registry updated 2026-02-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DOAC - Dosing Options in AntiCoagulation Prophylaxis | Embolism and Thrombosis, Thromboembolism, cancer, cardiovascular disorder, neoplasm, vascular disorder, venous thromboembolism | Recruiting | Phase 3 | 2026-02-05 | NCT07005024 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Vermont | 35 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Vermont Medical Center | Burlington | United States | 157 |